Andere talen Curis, Inc.

Aandelen

CRIS

US2312693094

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,52 ^USD	-1,69%		-4,60%	+13,88%

09/02	CURIS, INC. : HC Wainwright nog altijd een koopadvies	ZM
08/02	Curis, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Curis Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	08/04
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/04
Curis to Present at Upcoming Healthcare Conferences in April	04/04
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)	02/04
Curis Provides Fourth Quarter 2023 Business Update	09/02
Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/02
Curis: Q4 Earnings Snapshot	08/02
Earnings Flash (CRIS) CURIS Reports Q4 Revenue $2.7M, vs. Street Est of $3.1M	08/02
Curis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/02
Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024	01/02
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/01
Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study	12/12
Curis, Inc. Announces Initial Combination Study Data from Its Take Aim Lymphoma Study	12/12
Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference	11/12
Curis Enters into Agreement for Emavusertib, Pembrolizumab Combination Study in Melanoma	06/12
Curis Announces Three Presentations at ASH	06/12
Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma	05/12
Curis, Inc. Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma	05/12
Curis: Q3 Earnings Snapshot	02/11
Earnings Flash (CRIS) CURIS Posts Q3 Revenue $2.8M, vs. Street Est of $2.6M	02/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Curis, Inc.

Aandelen

CRIS

US2312693094

Andere talen

Filters